FDA 483 - Davis City Pharmacy Inc. - February 18, 2022

Davis City Pharmacy Inc. in Weatherford, TX, was cited for significant deficiencies in its non-sterile drug compounding operations. Observations included inadequate containment and cleaning procedures for potent/hazardous drugs, poor facility conditions, and failures in drug product testing and record-keeping. These issues raise concerns about product quality, safety, and potential cross-contamination.